J Clin Invest 2005;115:1343-1351
Initially, GLP-1s were developed to treat type 2 diabetes and were marketed for that purpose under brand names such as Ozempic (semaglutide), Rybelsus (semaglutide), Victoza (liraglutide), and Mounjaro (tirzepatide)
Howeverand this matters deeplyremoving ultra-processed foods does not automatically restore normal appetite signaling
Additionally, while some studies raise concerns about GLP-1s increasing depression, anxiety, and suicidal thoughts, other studies point in the opposite direction, noting a decrease in depressive symptoms, improved cognitive function, and an increase in feelings of self-mastery
[DOI] [PubMed] [Google Scholar] 65.Louie JK, Acosta M, Samuel MC, Schechter R, Vugia DJ, Harriman K
For patients throughout the St